Use your antibodies-online credentials, if available.
抗Human HBXIP 抗体:
抗Mouse (Murine) HBXIP 抗体:
抗Rat (Rattus) HBXIP 抗体:
Overall, the available data depict a self-inhibitory feedback loop in which HBV, through HBx, increases the expression of miR (显示 MYLIP 抗体)-125a, that in turn interferes with expression of HBV surface antigen, thus repressing viral replication.
Data show that hepatitis B X-interacting protein (HBXIP) modulated Methyltransferase-like 3 (METTL3 (显示 METTL3 抗体)) by inhibiting miRNA let-7g, which down-regulated the expression of METTL3 (显示 METTL3 抗体) by targeting its 3'UTR (显示 UTS2R 抗体).
Those findings highlight the potential role of SIRT2 (显示 SIRT2 抗体) in HBV and HBV-mediated HCC (显示 FAM126A 抗体) by interaction with HBx.
HBXIP can modulate the etoposide sensitivity of MCF-7 cell lines.
deacetylation of MST1 mediated by HBXIP-enhanced HDAC6 results in MST1 degradation in a CMA manner in promotion of breast cancer growth.
HBXIP up-regulates YAP (显示 YAP1 抗体) expression via activating transcription factor c-Myb (显示 MYB 抗体) to facilitate the growth of hepatoma cells.
high level of expression of HBXIP is associated with the progression of non-small-cell lung cancer and may be a useful biomarker for poor prognostic evaluation and a potential molecular therapy target for patients with non-small-cell lung cancer
HBXIP is able to depress the gluconeogenesis in hepatoma cells by suppressing PCK1 (显示 PCK1 抗体) to promote hepatocarcinogenesis, involving miR (显示 MLXIP 抗体)-135a/FOXO1 (显示 FOXO1 抗体) axis and PI3K (显示 PIK3CA 抗体)/Akt (显示 AKT1 抗体)/p-FOXO1 (显示 FOXO1 抗体) pathway.
we conclude that the oncoprotein HBXIP contributes to the abnormal lipid metabolism in breast cancer
HBXIP can function as a mediator protein for DNA damage response signals to activate the G2/M checkpoint to maintain genome integrity and prevent cell death.
promotes cisplatin resistance and regulates CD147 via Sp1 (显示 PSG1 抗体) in ovarian cancer
This gene encodes a protein that specifically complexes with the C-terminus of hepatitis B virus X protein (HBx). The function of this protein is to negatively regulate HBx activity and thus to alter the replication life cycle of the virus.
hepatitis B virus x interacting protein
, hepatitis B virus x-interacting protein
, Hepatitis B virus X-interacting protein
, HBV X-interacting protein homolog
, HBX-interacting protein homolog
, hepatitis B virus X-interacting protein homolog
, late endosomal/lysosomal adaptor and MAPK and MTOR activator 5
, ragulator complex protein LAMTOR5
, HBV X-interacting protein
, HBx-interacting protein
, hepatitis B virus x-interacting protein (9.6kD)
, Hepatitis B virus X-interacting protein homolog